questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Métalloprotéines
Protéines de liaison au fer
Protéines à fer non hème
Lipoxygénases
Arachidonate lipoxygenases
Arachidonate lipoxygenases : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Lipoxygénases
Acide arachidonique
Tests enzymatiques
Leucotriènes
Tests génétiques
Mutations
Analyse sanguine
Métabolites
Symptômes
5
Douleurs articulaires
Inflammation
Affections cutanées
Eczéma
Allergies
Réponse allergique
Prévention
5
Prévention
Alimentation équilibrée
Exercice physique
Inflammation
Compléments alimentaires
Oméga-3
Traitements
5
Inhibiteurs
Anti-inflammatoires
Corticostéroïdes
Expression génique
Acides gras oméga-3
Modulation
Plantes médicinales
Propriétés anti-inflammatoires
Thérapie génique
Mutations
Complications
5
Maladies inflammatoires
Asthme
Maladies cardiovasculaires
Inflammation
Troubles respiratoires
Leucotriènes
Troubles métaboliques
Déséquilibres
Cancers
Progression tumorale
Facteurs de risque
5
Hérédité
Antécédents familiaux
Polluants environnementaux
Exposition
Vieillissement
Inflammation
Stress oxydatif
Inflammation
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Arachidonate lipoxygenases : Questions médicales les plus fréquentes",
"headline": "Arachidonate lipoxygenases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Arachidonate lipoxygenases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-15",
"dateModified": "2025-04-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Arachidonate lipoxygenases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Lipoxygénases",
"url": "https://questionsmedicales.fr/mesh/D058945",
"about": {
"@type": "MedicalCondition",
"name": "Lipoxygénases",
"code": {
"@type": "MedicalCode",
"code": "D058945",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.556.579.374.568"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Arachidonate 5-lipoxygenase",
"alternateName": "Arachidonate 5-Lipoxygenase",
"url": "https://questionsmedicales.fr/mesh/D001094",
"about": {
"@type": "MedicalCondition",
"name": "Arachidonate 5-lipoxygenase",
"code": {
"@type": "MedicalCode",
"code": "D001094",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.556.579.374.568.500.020"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Arachidonate 12-lipoxygenase",
"alternateName": "Arachidonate 12-Lipoxygenase",
"url": "https://questionsmedicales.fr/mesh/D001092",
"about": {
"@type": "MedicalCondition",
"name": "Arachidonate 12-lipoxygenase",
"code": {
"@type": "MedicalCode",
"code": "D001092",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.556.579.374.568.500.025"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Arachidonate 15-lipoxygenase",
"alternateName": "Arachidonate 15-Lipoxygenase",
"url": "https://questionsmedicales.fr/mesh/D001093",
"about": {
"@type": "MedicalCondition",
"name": "Arachidonate 15-lipoxygenase",
"code": {
"@type": "MedicalCode",
"code": "D001093",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.556.579.374.568.500.030"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Arachidonate lipoxygenases",
"alternateName": "Arachidonate Lipoxygenases",
"code": {
"@type": "MedicalCode",
"code": "D001091",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Hartmut Kuhn",
"url": "https://questionsmedicales.fr/author/Hartmut%20Kuhn",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, D-10117 Berlin, Germany."
}
},
{
"@type": "Person",
"name": "Dagmar Heydeck",
"url": "https://questionsmedicales.fr/author/Dagmar%20Heydeck",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität Zu Berlin, Charitéplatz 1, 10117, Berlin, Germany."
}
},
{
"@type": "Person",
"name": "Deok-Kun Oh",
"url": "https://questionsmedicales.fr/author/Deok-Kun%20Oh",
"affiliation": {
"@type": "Organization",
"name": "Department of Bioscience and Biotechnology, Konkuk University, Seoul, 05029, Republic of Korea. deokkun@konkuk.ac.kr."
}
},
{
"@type": "Person",
"name": "Sabine Stehling",
"url": "https://questionsmedicales.fr/author/Sabine%20Stehling",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, D-10117 Berlin, Germany."
}
},
{
"@type": "Person",
"name": "Michael Rothe",
"url": "https://questionsmedicales.fr/author/Michael%20Rothe",
"affiliation": {
"@type": "Organization",
"name": "Lipidomix GmbH, Robert-Rössle-Straße 10, 13125, Berlin, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Injection Site Reactions Before and After Intramuscular Injection Technique Revision: A Postmarketing Analysis of NALDEBAIN® From 2017 to 2022.",
"datePublished": "2023-05-04",
"url": "https://questionsmedicales.fr/article/37160663",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.6859/aja.202303_61(1).0002"
}
},
{
"@type": "ScholarlyArticle",
"name": "Injection Site Reactions with Long-Term Pegcetacoplan Use in Patients with Paroxysmal Nocturnal Hemoglobinuria: A Brief Report.",
"datePublished": "2023-09-14",
"url": "https://questionsmedicales.fr/article/37707673",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12325-023-02653-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Injection Site Reaction to Various Insulins as Type III Allergy With Urticarial Vasculitis in a Patient With Type I Diabetes Mellitus.",
"datePublished": "2022-12-07",
"url": "https://questionsmedicales.fr/article/36669070",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/DAD.0000000000002356"
}
},
{
"@type": "ScholarlyArticle",
"name": "Fremanezumab-associated injection site alopecia.",
"datePublished": "2024-08-12",
"url": "https://questionsmedicales.fr/article/39134332",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bcr-2024-260741"
}
},
{
"@type": "ScholarlyArticle",
"name": "Lower injection-site reactions and long-term safety, immunogenicity, and efficacy of etanercept biosimilar YLB113: Results from a post-hoc analysis of a double-blind, randomized, phase III comparative study and its open-label extension in patients with rheumatoid arthritis.",
"datePublished": "2022-10-17",
"url": "https://questionsmedicales.fr/article/36253032",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/1756-185X.14462"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Métalloprotéines",
"item": "https://questionsmedicales.fr/mesh/D008667"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines de liaison au fer",
"item": "https://questionsmedicales.fr/mesh/D033862"
},
{
"@type": "ListItem",
"position": 6,
"name": "Protéines à fer non hème",
"item": "https://questionsmedicales.fr/mesh/D019159"
},
{
"@type": "ListItem",
"position": 7,
"name": "Lipoxygénases",
"item": "https://questionsmedicales.fr/mesh/D058945"
},
{
"@type": "ListItem",
"position": 8,
"name": "Arachidonate lipoxygenases",
"item": "https://questionsmedicales.fr/mesh/D001091"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Arachidonate lipoxygenases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Arachidonate lipoxygenases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Arachidonate lipoxygenases",
"description": "Comment diagnostiquer une dysfonction des lipoxygénases ?\nQuels tests sont utilisés pour évaluer l'activité des lipoxygénases ?\nLes tests génétiques sont-ils utiles pour les lipoxygénases ?\nQuels symptômes peuvent indiquer un problème avec les lipoxygénases ?\nPeut-on mesurer les niveaux de lipoxygénases dans le sang ?",
"url": "https://questionsmedicales.fr/mesh/D001091?mesh_terms=Injection+Site+Reaction#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Arachidonate lipoxygenases",
"description": "Quels symptômes sont liés à une surproduction de leucotriènes ?\nLes douleurs articulaires peuvent-elles être liées aux lipoxygénases ?\nComment les lipoxygénases affectent-elles la peau ?\nLes allergies peuvent-elles être influencées par les lipoxygénases ?\nQuels signes indiquent une inflammation due aux lipoxygénases ?",
"url": "https://questionsmedicales.fr/mesh/D001091?mesh_terms=Injection+Site+Reaction#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Arachidonate lipoxygenases",
"description": "Comment prévenir les troubles liés aux lipoxygénases ?\nL'exercice physique influence-t-il les lipoxygénases ?\nLe stress a-t-il un impact sur les lipoxygénases ?\nLes habitudes de vie peuvent-elles influencer les lipoxygénases ?\nLes compléments alimentaires sont-ils bénéfiques pour les lipoxygénases ?",
"url": "https://questionsmedicales.fr/mesh/D001091?mesh_terms=Injection+Site+Reaction#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Arachidonate lipoxygenases",
"description": "Quels médicaments ciblent les lipoxygénases ?\nLes corticostéroïdes affectent-ils l'activité des lipoxygénases ?\nComment les acides gras oméga-3 influencent-ils les lipoxygénases ?\nLes traitements naturels peuvent-ils aider avec les lipoxygénases ?\nLa thérapie génique est-elle une option pour les troubles des lipoxygénases ?",
"url": "https://questionsmedicales.fr/mesh/D001091?mesh_terms=Injection+Site+Reaction#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Arachidonate lipoxygenases",
"description": "Quelles complications peuvent survenir avec une dysfonction des lipoxygénases ?\nLes maladies cardiovasculaires sont-elles liées aux lipoxygénases ?\nLes troubles respiratoires peuvent-ils être aggravés par les lipoxygénases ?\nLes troubles métaboliques sont-ils associés aux lipoxygénases ?\nLes cancers peuvent-ils être influencés par les lipoxygénases ?",
"url": "https://questionsmedicales.fr/mesh/D001091?mesh_terms=Injection+Site+Reaction#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Arachidonate lipoxygenases",
"description": "Quels facteurs de risque sont associés aux troubles des lipoxygénases ?\nL'hérédité joue-t-elle un rôle dans les troubles des lipoxygénases ?\nL'exposition à des polluants affecte-t-elle les lipoxygénases ?\nLe vieillissement influence-t-il l'activité des lipoxygénases ?\nLe stress oxydatif est-il un facteur de risque pour les lipoxygénases ?",
"url": "https://questionsmedicales.fr/mesh/D001091?mesh_terms=Injection+Site+Reaction#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction des lipoxygénases ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests biochimiques et l'analyse des métabolites lipidiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'activité des lipoxygénases ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques et des dosages de leucotriènes dans le sang sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour les lipoxygénases ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests génétiques peuvent identifier des mutations affectant l'activité des lipoxygénases."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème avec les lipoxygénases ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes d'inflammation chronique, comme l'asthme ou l'arthrite, peuvent survenir."
}
},
{
"@type": "Question",
"name": "Peut-on mesurer les niveaux de lipoxygénases dans le sang ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des analyses sanguines peuvent mesurer les niveaux d'enzymes et de métabolites."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une surproduction de leucotriènes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surproduction peut entraîner des symptômes respiratoires, comme la dyspnée et la toux."
}
},
{
"@type": "Question",
"name": "Les douleurs articulaires peuvent-elles être liées aux lipoxygénases ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une activité anormale des lipoxygénases peut contribuer à l'inflammation articulaire."
}
},
{
"@type": "Question",
"name": "Comment les lipoxygénases affectent-elles la peau ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent jouer un rôle dans des affections cutanées inflammatoires comme l'eczéma."
}
},
{
"@type": "Question",
"name": "Les allergies peuvent-elles être influencées par les lipoxygénases ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les lipoxygénases sont impliquées dans la réponse allergique et l'inflammation."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une inflammation due aux lipoxygénases ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rougeur, chaleur, gonflement et douleur sont des signes d'inflammation active."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles liés aux lipoxygénases ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et riche en oméga-3 peut aider à prévenir l'inflammation."
}
},
{
"@type": "Question",
"name": "L'exercice physique influence-t-il les lipoxygénases ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut réduire l'inflammation et moduler l'activité des lipoxygénases."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur les lipoxygénases ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut augmenter l'inflammation et affecter l'activité des lipoxygénases."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie peuvent-elles influencer les lipoxygénases ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes de vie saines, comme éviter le tabac, peuvent réduire les risques."
}
},
{
"@type": "Question",
"name": "Les compléments alimentaires sont-ils bénéfiques pour les lipoxygénases ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des compléments d'oméga-3 peuvent aider à réguler l'activité des lipoxygénases."
}
},
{
"@type": "Question",
"name": "Quels médicaments ciblent les lipoxygénases ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs spécifiques des lipoxygénases, comme les anti-inflammatoires, sont utilisés."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes affectent-ils l'activité des lipoxygénases ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les corticostéroïdes peuvent réduire l'expression des lipoxygénases et l'inflammation."
}
},
{
"@type": "Question",
"name": "Comment les acides gras oméga-3 influencent-ils les lipoxygénases ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les oméga-3 peuvent moduler l'activité des lipoxygénases et réduire l'inflammation."
}
},
{
"@type": "Question",
"name": "Les traitements naturels peuvent-ils aider avec les lipoxygénases ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines plantes médicinales ont des propriétés anti-inflammatoires et peuvent aider."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option pour les troubles des lipoxygénases ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est en recherche pour corriger des mutations affectant les lipoxygénases."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une dysfonction des lipoxygénases ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des maladies inflammatoires chroniques comme l'asthme et l'arthrite."
}
},
{
"@type": "Question",
"name": "Les maladies cardiovasculaires sont-elles liées aux lipoxygénases ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une activité anormale des lipoxygénases peut contribuer à l'inflammation cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Les troubles respiratoires peuvent-ils être aggravés par les lipoxygénases ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surproduction de leucotriènes peut aggraver des troubles respiratoires comme l'asthme."
}
},
{
"@type": "Question",
"name": "Les troubles métaboliques sont-ils associés aux lipoxygénases ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des déséquilibres dans l'activité des lipoxygénases peuvent être liés à des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Les cancers peuvent-ils être influencés par les lipoxygénases ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent que les lipoxygénases peuvent jouer un rôle dans la progression tumorale."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont associés aux troubles des lipoxygénases ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme l'obésité, le tabagisme et une alimentation riche en graisses saturées augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'hérédité joue-t-elle un rôle dans les troubles des lipoxygénases ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies inflammatoires peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "L'exposition à des polluants affecte-t-elle les lipoxygénases ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des polluants environnementaux peut altérer l'activité des lipoxygénases."
}
},
{
"@type": "Question",
"name": "Le vieillissement influence-t-il l'activité des lipoxygénases ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut modifier l'activité des lipoxygénases et augmenter l'inflammation."
}
},
{
"@type": "Question",
"name": "Le stress oxydatif est-il un facteur de risque pour les lipoxygénases ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress oxydatif peut exacerber l'inflammation et affecter l'activité des lipoxygénases."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 09/04/2025
Contenu vérifié selon les dernières recommandations médicales
8 publications dans cette catégorie
Affiliations :
Department of Biochemistry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, D-10117 Berlin, Germany.
5 publications dans cette catégorie
Affiliations :
Department of Biochemistry, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität Zu Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Publications dans "Arachidonate lipoxygenases" :
5 publications dans cette catégorie
Affiliations :
Department of Bioscience and Biotechnology, Konkuk University, Seoul, 05029, Republic of Korea. deokkun@konkuk.ac.kr.
Department of Integrative Bioscience and Biotechnology, Konkuk University, Seoul, 05029, Republic of Korea. deokkun@konkuk.ac.kr.
Publications dans "Arachidonate lipoxygenases" :
4 publications dans cette catégorie
Affiliations :
Department of Biochemistry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, D-10117 Berlin, Germany.
Publications dans "Arachidonate lipoxygenases" :
4 publications dans cette catégorie
Affiliations :
Lipidomix GmbH, Robert-Rössle-Straße 10, 13125, Berlin, Germany.
Publications dans "Arachidonate lipoxygenases" :
4 publications dans cette catégorie
Affiliations :
Department of Integrative Bioscience and Biotechnology, Konkuk University, Seoul, 05029, Republic of Korea.
Publications dans "Arachidonate lipoxygenases" :
4 publications dans cette catégorie
Affiliations :
Department of Biochemistry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, D-10117 Berlin, Germany.
Publications dans "Arachidonate lipoxygenases" :
3 publications dans cette catégorie
Affiliations :
William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, John Vane Science Centre, Queen Mary University of London, London, United Kingdom.
Publications dans "Arachidonate lipoxygenases" :
3 publications dans cette catégorie
Affiliations :
Department of Otolaryngology, Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, 100730 People's Republic of China.
Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, 100005 People's Republic of China.
Department of Allergy, Beijing TongRen Hospital, Capital Medical University, Beijing, 100730 People's Republic of China.
Research Unit of Diagnosis and Treatment of Chronic Nasal Diseases, Chinese Academy of Medical Sciences, Beijing, 100005 People's Republic of China.
Publications dans "Arachidonate lipoxygenases" :
3 publications dans cette catégorie
Affiliations :
Faculty of Medicine, Institute of Biochemistry I, Goethe University Frankfurt, Frankfurt, Germany.
Frankfurt Cancer Institute, Goethe University Frankfurt, Frankfurt, Germany.
German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany.
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt, Germany.
Publications dans "Arachidonate lipoxygenases" :
3 publications dans cette catégorie
Affiliations :
Department of Nutritional Science, Okayama Prefectural University, 111 Kuboki, Soja, Okayama, 719-1197, Japan.
Publications dans "Arachidonate lipoxygenases" :
3 publications dans cette catégorie
Affiliations :
Department of Nutritional Science, Okayama Prefectural University, 111 Kuboki, Soja, Okayama, 719-1197, Japan.
Publications dans "Arachidonate lipoxygenases" :
3 publications dans cette catégorie
Affiliations :
Department of Nutritional Science, Okayama Prefectural University, 111 Kuboki, Soja, Okayama, 719-1197, Japan.
Publications dans "Arachidonate lipoxygenases" :
3 publications dans cette catégorie
Affiliations :
Department of Nutritional Science, Okayama Prefectural University, 111 Kuboki, Soja, Okayama, 719-1197, Japan. Electronic address: toshiko@fhw.oka-pu.ac.jp.
Publications dans "Arachidonate lipoxygenases" :
3 publications dans cette catégorie
Affiliations :
Department of Bioscience and Biotechnology, Konkuk University, Seoul, 05029, Republic of Korea.
Publications dans "Arachidonate lipoxygenases" :
3 publications dans cette catégorie
Affiliations :
Department of Chemistry, School of Science and Engineering, American University in Cairo, New Cairo 11835, Cairo, Egypt.
Publications dans "Arachidonate lipoxygenases" :
2 publications dans cette catégorie
Affiliations :
Centre for Tumour Biology, Barts Cancer Institute, London, United Kingdom.
Publications dans "Arachidonate lipoxygenases" :
2 publications dans cette catégorie
Affiliations :
Centre for Tumour Biology, Barts Cancer Institute, London, United Kingdom.
Publications dans "Arachidonate lipoxygenases" :
2 publications dans cette catégorie
Affiliations :
Centre for Tumour Biology, Barts Cancer Institute, London, United Kingdom.
Publications dans "Arachidonate lipoxygenases" :
2 publications dans cette catégorie
Affiliations :
Department of Otolaryngology, Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, 100730 People's Republic of China.
Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, 100005 People's Republic of China.
Research Unit of Diagnosis and Treatment of Chronic Nasal Diseases, Chinese Academy of Medical Sciences, Beijing, 100005 People's Republic of China.
Publications dans "Arachidonate lipoxygenases" :
The NALDEBAIN® has been available since 2017, and high incidence of injection reactions in the phase 3 study has been reported. Since the first year in the market, the injection site reactions were st...
Individual case safety reports (ICSRs) and ADRs were classified by system organ class and preferred term. The reporting rate of ICSRs was used to evaluate the impact of the new IM instruction and pack...
A total of 37 ICSRs were identified from pharmacovigilance reports. Among them, 51% of IM injection-related reactions were reported after one single dose of NALDEBAIN administration. The reporting rat...
Injection site reactions were common after intramuscularly administered oil-based agents during the first year which is later markedly reduced by changing the length of the needle and injection educat...
Pegcetacoplan is a targeted complement component 3 (C3) therapy approved for adults with paroxysmal nocturnal hemoglobinuria (PNH; US) or PNH plus anemia despite C5-targeted therapy for ≥ 3 months (EU...
Patients from PEGASUS enrolled in the 307 OLE continued pegcetacoplan subcutaneous self-administration twice or three times weekly or every 3 days for an additional 48 weeks. ISRs were coded as advers...
As of August 27, 2021, 58/64 patients from PEGASUS completed an additional 48 weeks of treatment in the 307 OLE (median treatment duration 337.0 [range 55-344] days); 95.3% (61/64) of patients achieve...
Though ISRs were common, most were mild, and the percentage of patients reporting ISRs declined from PEGASUS through the 307 OLE. Patient compliance remained high, and no patients discontinued because...
ClinicalTrials.gov identifiers: NCT03500549 (PEGASUS) and NCT03531255 (307 OLE)....
Injection site reactions are defined as skin reactions at the injection site to drugs administered subcutaneously. Pathophysiologically, these reactions are based on different immunological mechanisms...
Calcitonin gene-related peptide (CGRP) inhibitors, in the form of injectable monoclonal antibodies, are a newer class of drugs for the prevention of migraine headaches. In clinical trials, they have b...
YLB113 biosimilar was evaluated in an open-label extension single-arm study to assess long-term safety, efficacy, and immunogenicity in patients with rheumatoid arthritis (RA). We also report post-hoc...
Participants from the phase III, double-blind, randomized, 96 week equivalence study who completed the final visit received 50 mg YLB113 subcutaneously every 2 weeks. Key safety end points were assess...
Of 201 participants, 184 (91.5%) completed the study. Treatment-emergent AEs were experienced by 93.5% and severe AEs by 10.0% of participants. The discontinuation rate due to AEs was 2.0%. Overall, 2...
YLB113 demonstrated long-term safety and sustained efficacy for up to 96 weeks. Patients on YLB113 experienced significantly lower ISRs and ISE in a post-hoc analysis of the phase III study when compa...
A male in his 70s developed a rash on his lower abdomen after changing his subcutaneous injection drug from dulaglutide to tirzepatide. The rash diminished after stopping tirzepatide injection. This c...
Dupilumab is a humanized monoclonal antibody approved for the treatment of chronic rhinosinusitis with nasal polyposis (CRSwNP), asthma, atopic dermatitis, eosinophilic esophagitis, and prurigo nodula...
Cabotegravir (CAB) + rilpivirine (RPV) dosed monthly or every 2 months is a complete long-acting (LA) regimen for the maintenance of human immunodeficiency virus type 1 virologic suppression. Across t...
We present pooled ISR characteristics and outcomes for participants receiving CAB + RPV LA through week 96 of the FLAIR and ATLAS-2M studies, and survey results from healthcare providers (HCPs) giving...
Overall, 8453 ISRs were reported by 801 participants receiving ≥1 injection of CAB LA/RPV LA. Most ISRs were mild to moderate in severity (grade 1-2, 99%), with a median duration of 3 days (interquart...
Taken together, the data demonstrate favorable tolerability with CAB + RPV LA injections over the long term and simple techniques routinely used by injectors to help optimize the administration of CAB...
Transient swelling is common after lip injections with hyaluronic acid (HA) based fillers. Swelling and other injection-site reactions may relate to the injection procedure itself, or to gel propertie...
To evaluate safety and effectiveness of lip injections with two HA fillers manufactured using different gel technologies....
In a study sample of 40 subjects, treatment with two soft tissue filler product (HA...
In subjects treated with HA...
The intensity of early-onset swelling, and other injection-site reactions was lower in subjects treated with HA...
Biologic selection for psoriasis treatment should take into account numerous factors including injection site reactions (ISRs) such as swelling at the injection site, pain, burning, erythema, all poss...
A 6-months observational real life study was performed involving psoriasis patients. Inclusion criteria were age ≥ 18 years, moderate-to-severe psoriasis diagnosis since at least 1 year, patients bein...
234 patients were included: 32.5% received an anti-TNF-alpha drug, 9.4% received anti-IL12/23, 32.5% received an anti-IL17, 25.6% received an anti-IL23. 51.2% of study population reported at least one...
Our study highlighted that each different class of biologics for psoriasis was linked to ISRs. These events are more frequently reported with anti-TNF-alpha and anti-IL17....